APA (7th ed.) Citation

L, P., AA, D., L, G., AJ, M., J, W., E, N., . . . M, C. (2025). Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: A retrospective multi-institutional Consortium analysis. NPJ breast cancer, 11(1), 93. https://doi.org/10.1038/s41523-025-00802-2

Chicago Style (17th ed.) Citation

L, Pontolillo, et al. "Circulating Genomic Landscape Following Cyclin-dependent Kinase 4/6 Inhibitors Exposure in HR + /HER2- Metastatic Breast Cancer: A Retrospective Multi-institutional Consortium Analysis." NPJ Breast Cancer 11, no. 1 (2025): 93. https://doi.org/10.1038/s41523-025-00802-2.

MLA (9th ed.) Citation

L, Pontolillo, et al. "Circulating Genomic Landscape Following Cyclin-dependent Kinase 4/6 Inhibitors Exposure in HR + /HER2- Metastatic Breast Cancer: A Retrospective Multi-institutional Consortium Analysis." NPJ Breast Cancer, vol. 11, no. 1, 2025, p. 93, https://doi.org/10.1038/s41523-025-00802-2.